Clinical Trial

Metabolic Phenotypes in Melanoma

Name: Metabolic Phenotypes in Melanoma — clinical trial record (NCT05570227)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MetaMel

Recruiting

View on ClinicalTrials.gov →

Summary

This is a single centre, correlative, longitudinal, biomarker study that aims to describe the metabolic features of human melanoma using mass spectrometry.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2022-10-04; most recent amendment 2023-07-03.

Status change: Not Yet Recruiting → Recruiting 2023-07-03

Trial Details

NCT Number	NCT05570227
Lead Sponsor	Peter MacCallum Cancer Centre, Australia
Conditions	Melanoma
Enrollment	240 participants
Start Date	2023-06-27
Primary Completion	2027-10 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2023-07-06